EKSO Stock: Ekso Bionics Holdings, Inc. Stock Price, Analysis & Insights
Get live ekso stock price $8.64, comprehensive Ekso Bionics Holdings, Inc. stock analysis, charts, news, and expert forecast. Real-time ekso stock data and investment insights.
Loading chart...
Company Overview
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Company Information
- CEO
- Scott G. Davis
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 61
Contact Information
- Website
- https://www.eksobionics.com
- Address
- 1414 Harbour Way South
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Ekso Bionics Holdings, Inc. operates in the Medical - Instruments & Supplies industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Scott G. Davis, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Instruments & Supplies model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Ekso Bionics Holdings, Inc. competes in the Medical - Instruments & Supplies within the broader Healthcare. With 22.7 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Ekso Bionics Holdings, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Ekso Bionics Holdings, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Ekso Bionics Holdings, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Ekso Bionics Holdings, Inc.
- ⚠Investors should consider how Ekso Bionics Holdings, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
22.66M
P/E Ratio
-1.61
Beta
0.82
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 22.66M market capitalization
- Trading Volume: 3.66M shares traded today
- Price Range: 52-week range of $2.73 - $14.97
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings, Inc. (EKSO) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 22.66M, the company represents a significant player in its market. The stock is currently trading at $8.64 with a negativedaily change of 18.34%.
The company's 61 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -1.61, beta of 0.82, and 52-week price range from $2.73 to $14.97when evaluating investment opportunities.
Why Invest in Ekso Bionics Holdings, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Scott G. Davis
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.